Patents Examined by Nannette Holloman
  • Patent number: 11547722
    Abstract: Disclosed are a composition containing a transition metal, as well as a method of treatment of bacterial, or of fungal diseases using such composition. The composition functions as novel bactericides and antifungal agents. The transition metal may be in either soluble or insoluble form.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: January 10, 2023
    Inventor: Jean-Jacques Walter
  • Patent number: 11541002
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: January 3, 2023
    Assignee: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Patent number: 11523994
    Abstract: The invention relates to a sprayable liquid solution for the transdermal delivery of testosterone comprising testosterone, a penetration enhancer, and a film forming excipient, and to methods of treatment using this composition.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: December 13, 2022
    Assignee: CELISTA PHARMACEUTICALS LLC
    Inventors: Yogesh Dandiker, Maulik Kiritkumar Panchal
  • Patent number: 11524071
    Abstract: The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a coronavirus vaccine adjuvant.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: December 13, 2022
    Assignee: 3M Innovative Properties Company
    Inventor: Paul D. Wightman
  • Patent number: 11517774
    Abstract: The present invention relates to compositions for removing nail polish that include a C2-C3 monoalcohol, at least about 15% glycerin, and at least about 20% by weight of a C2-C4 alkyl acetate, and combinations thereof. The compositions include less water than glycerin. Methods of using these compositions to remove nail polish and moisturize the hands are also provided.
    Type: Grant
    Filed: November 11, 2020
    Date of Patent: December 6, 2022
    Assignee: L'OREAL
    Inventors: Andrea E. Schott, Aline Aude Guimont
  • Patent number: 11510855
    Abstract: The present disclosure relates to topical sunscreen formulations comprising a semifluorinated alkane and a metal oxide selected from titanium dioxide, zinc oxide or mixtures thereof.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: November 29, 2022
    Assignee: DERMALIQ THERAPEUTICS, INC.
    Inventors: Frank Löscher, Ralf Grillenberger, Chiara Silvana Leo, Markus Beier
  • Patent number: 11504312
    Abstract: An oral care mouth rinse composition containing at least one ionic tin source and polyvinylpyrrolidone wherein the polyvinylpyrrolidone is present in an amount of from 1.5 to 4 weight % based on the total weight of the oral care mouth rinse composition is provided.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: November 22, 2022
    Assignee: Colgate-Palmolive Company
    Inventors: Sylvia Hess, Ruth Hinrichs, Stephanie Jakumeit, Turan Matur, Andre Brunella, Peter Reiff
  • Patent number: 11491106
    Abstract: A single-use, oral dosage forms (e.g., fast-dissolving strips) is disclosed, as well as methods of using such oral dosage forms to sweeten edible compositions. Methods of manufacturing single-use, oral dosage forms are also provided.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: November 8, 2022
    Assignee: The Coca-Cola Company
    Inventors: Youlung Chen, Xiaoliang Tan, Juvenal Higiro, Indra Prakash, Robert M. Kriegel, Yu Shi, Haiyu Ren
  • Patent number: 11491161
    Abstract: Provided herein are methods for treating pulmonary hypertension. The methods include administering to a subject in need thereof an effective amount of a vasodilator, wherein the vasodilator is administered to the subject via inhalation pro re nata using a portable inhaler. In some embodiments, the vasodilator is a PDE5 inhibitor. Pharmaceutical compositions for pro re nata administration of vasodilators are also described.
    Type: Grant
    Filed: November 23, 2021
    Date of Patent: November 8, 2022
    Assignee: Respira Therapeutics, Inc.
    Inventors: Jeffry Weers, Alain Romero, Hugh Smyth, Robert Curtis, Adaani Frost, Zhen Xu, Revati Shreeniwas, Martin Donovan
  • Patent number: 11491160
    Abstract: Provided herein are methods for treating pulmonary hypertension. The methods include administering to a subject in need thereof an effective amount of a vasodilator, wherein the vasodilator is administered to the subject via inhalation pro re nata using a portable inhaler. In some embodiments, the vasodilator is a PDE5 inhibitor. Pharmaceutical compositions for pro re nata administration of vasodilators are also described.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: November 8, 2022
    Assignee: Respira Therapeutics, Inc.
    Inventors: Jeffry Weers, Alain Romero, Hugh Smyth, Robert Curtis, Adaani Frost, Zhen Xu, Revati Shreeniwas, Martin Donovan
  • Patent number: 11484485
    Abstract: Photostabilizing compounds are provided. In particular, the photostabilizing compounds may be heterocyclic or homocyclic. Topical compositions comprising these compounds are also provided. In particular, these topical compositions may further comprise photoactive compounds. Methods for stabilizing photoactive compounds are also provided. These methods comprise mixing the photoactive compounds with photostabilizing compounds.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: November 1, 2022
    Assignee: ELC MANAGEMENT LLC
    Inventor: Craig Alan Bonda
  • Patent number: 11478459
    Abstract: The present invention relates to a solid pharmaceutical preparation of 3-Fluoro-4-[7-methoxy-3-methyl-8-(1-methyl-1H-pyrazol-4-yl)-2-oxo-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl]-benzonitrile, a method of making same, and medical uses thereof.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: October 25, 2022
    Assignee: Merck Patent GmbH
    Inventors: Simon Geissler, Stefan Schiller, Meike Harms, Holger Kubas, Markus Weigandt, Michael Lange
  • Patent number: 11464769
    Abstract: The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: October 11, 2022
    Assignee: VYLUMA INC.
    Inventors: Navneet Puri, Prem Sagar Akasapu, Irfan A. Mohammed, Kumaresh Soppimath, Iouri V. Ilitchev
  • Patent number: 11464714
    Abstract: The invention relates to a W/O emulsion for impregnating nonwoven containing 10-60% by weight of vegetable oil, 0.1-25% by weight of emollients, 10 to 50% by weight of water, a lipophilic emulsifier, an inorganic salt as well as at least one antioxidant, wherein the emulsifier is polyglyceryl-4-diisostearate/polyhydroxystearate/sebacate and the viscosity of the emulsion is 250-600 mPa·s, determined using a DIN measuring system 33 according to ISO 53019 at a temperature of 293.15 K and at a rotation speed of 500 r/min.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: October 11, 2022
    Assignee: DR. SCHUMACHER GMBH
    Inventors: Mike Ballez, Julia Fuss, Jens Nielsen
  • Patent number: 11464726
    Abstract: The invention relates to the non-therapeutic use of a composition comprising at least one 1,4:3,6 dianhydrohexitol for moisturising the skin, as well as to a preparation for topical use comprising at least one 1,4:3,6 dianhydrohexitol as a moisturising agent.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: October 11, 2022
    Assignee: ROQUETTE FRERES
    Inventors: Daniel Wils, Léon Mentink
  • Patent number: 11452681
    Abstract: A cosmetic composition to prevent and/or ameliorate skin aging and applications thereof are provided in the present disclosure and the cosmetic composition comprises cyclic phosphatidic acid and citrus flavonoids which is hesperidin and/or hesperetin wherein the preventing and/or ameliorating skin aging include, without limitation, promoting moisture retention of stratum corneum, promoting skin elasticity, increasing presence or elasticity of collagens and elastins in fibroblasts, increasing transfers of fibroblasts, promoting anti-oxidation, increasing generation of hyaluronic acid, alleviating wrinkles and skin textures, moderating melanin, reducing skin oil and preventing transepidermal water losses.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: September 27, 2022
    Assignee: ORIENT EUROPHARMA CO., LTD.
    Inventors: Chin-Chih Chiang, Mon-Jer Tsai
  • Patent number: 11434144
    Abstract: The present invention relates to a detoxified powder composition comprising a zinc-bearing compound selected from the group consisting of zinc carbonate, zinc hydroxide, zinc oxide, zinc sulphate and mixtures thereof, and at least one detoxification agent containing at least one oxide based on a cation, selected from the group consisting of calcium, barium, magnesium, strontium and beryllium.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: September 6, 2022
    Assignee: SOCIETE INDUSTRIELLE LIEGEOISE DES OXYDES SA
    Inventor: Benoît Lebrun
  • Patent number: 11426336
    Abstract: A sunscreen composition is provided. The sunscreen composition includes non-nano zinc oxide, a carrier, and a component selected from the group consisting of a humectant, a thickener, a dispersing agent, an emulsifier, an emollient, a preservative, an antioxidant, an odorant, and combinations thereof. The sunscreen composition complies with the natural product standard governed by Cosmetics Organic and Natural Standard (non-profit) (“COSMOS-standard AISBL”).
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: August 30, 2022
    Assignee: LOVE SUN BODY IP HOLDINGS LLC
    Inventor: Terry Zickerman
  • Patent number: 11419808
    Abstract: A fibrous structure with a plurality of fibrous elements. The fibrous elements contain a polymeric structurant; a fatty material with a melting point above 25° C.; a cationic surfactant, which can be selected from the group consisting of a mono-long alkyl amine, a tertiary amine, and combinations thereof; and an oil soluble acid. The oil soluble acid can be selected from the group consisting of salicylic acid, lactic acid, acetic acid, malic acid, succinic acid, sorbic acid, 2,4-dihydroxybenzoic acid, maleic acid, and combinations thereof.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: August 23, 2022
    Assignee: The Procter & Gamble Company
    Inventors: Jennifer Elaine Hilvert, Mark William Hamersky, Emily Lao Hickey
  • Patent number: 11419800
    Abstract: The present disclosure provides compositions of rose oil, cannabidiol, and humectants and methods of using said compositions. The present disclosure also products containing the aforementioned products, including a face mask, a serum, a lotion, and an eye cream.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: August 23, 2022
    Assignee: JLABS Beauty LLC
    Inventors: Justine Mullen, Anne Schlesselman Buthion